|
Tabla 4: Manifestaciones neurológicas durante la hospitalización. |
|||||
|
Característica |
Total N = 31 n (%) |
mRS 0-1 N = 9 n (%) |
mRS 2 N = 11 n (%) |
mRS 3-5 N = 9 n (%) |
mRS 6 N = 2 n (%) |
|
Cefalea |
9 (29.0) |
3 (33.3) |
5 (55.6) |
1 (11.1) |
0 (0.0) |
|
Mareo |
1 (3.2) |
0 (0.0) |
0 (0.0) |
1 (100.0) |
0 (0.0) |
|
Somnolencia |
5 (16.1) |
0 (0.0) |
0 (0.0) |
4 (80.0) |
1 (20.0) |
|
Hipogeusia |
2 (6.4) |
1 (50.0) |
1 (50.0) |
0 (0.0) |
0 (0.0) |
|
Hiposmia |
1 (3.2) |
0 (0.0) |
1 (100.0) |
0 (0.0) |
0 (0.0) |
|
Alteración del lenguaje |
1 (3.2) |
0 (0.0) |
0 (0.0) |
1 (100.0) |
0 (0.0) |
|
Síntomas sensitivos |
2 (6.4) |
0 (0.0) |
1 (50.0) |
1 (50.0) |
0 (0.0) |
|
Delirium |
6 (19.3) |
0 (0.0) |
1 (16.7) |
4 (66.6) |
1 (16.7) |
|
Oftalmoparesia |
1 (3.2) |
0 (0.0) |
0 (0.0) |
1 (100.0) |
0 (0.0) |
|
Debilidad muscular aguda de causa desconocida |
5 (16.1) |
1 (20.0) |
2 (40.0) |
0 (0.0) |
2 (40.0) |
|
Daño isquémico difuso en la IRM |
7 (22.6) |
2 (28.6) |
3 (42.8) |
2 (28.6) |
0 (0.0) |
|
Incremento en mioglobina sérica |
7 (22.6) |
3 (42.8) |
1 (14.4) |
3 (42.8) |
0 (0.0) |
|
Neuropatía axonal en estudio de neruoconducción |
4 (12.9) |
0 (0) |
0 (0) |
4 (100.0) |
0 (0.0) |
|
mRS = escala de Rankin modificada. IRM = imagen de resonancia magnética. |
|||||